US$ 27.98
glp 1 analogues mechanism of action Frontiers Glucagon-like peptide-1 - Wikipedia
Description
Navigating the Impending Generics Entry Wegovy generics expected between 20262032 will likely reshape the market, particularly given the large self-pay, cost-sensitive patient base
Though not currently available for patient use, early research and development suggest that these patches may represent a promising evolution in the way medications are delivered

Novo Nordisk A/S 21.11

(2024) 73:855-P

1 for GLP-1s Novo needed this boost

London, UK: 2022
